CAG
VIVO

Csenge Advisory Group’s Meridian Bioscience Inc VIVO Stock Holding History

Csenge Advisory Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,335
Closed -$284K – 592
2021
Q1 		$284K Buy
+11,335
New +$270K 0.03% 395
2018
Q4 		– Sell
-11
Closed – – 1630
2018
Q3 		$0 Buy
+11
New +$171 ﹤0.01% 1755

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Csenge Advisory Group's VIVO Position: Q2 2021 in Review

Csenge Advisory Group sold out of Meridian Bioscience Inc (VIVO) in Q2 2021, closing a stake of 11,335 shares — an estimated $284K sold.

Csenge Advisory Group first reported a position in VIVO in Q3 2018 and held it in 2 quarters. The position peaked at $284K in Q1 2021. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

  • Csenge Advisory Group reported no remaining Meridian Bioscience Inc position as of Q2 2021 after selling out during the quarter.
  • Csenge Advisory Group sold 11,335 Meridian Bioscience Inc shares in Q2 2021, an estimated $284K.
  • Csenge Advisory Group first reported a position in Meridian Bioscience Inc in Q3 2018 and held it in 2 quarters.
  • Csenge Advisory Group's Meridian Bioscience Inc position peaked at $284K in Q1 2021.
  • 189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on Csenge Advisory Group's 13F filing for Q2 2021, filed 21 Jul 2021.